Brief: Somalogic Reports Q3 Financial Results
14/11/2022 17:50
Nov 14 (Reuters) - Somalogic Inc SLGC.O :
* SOMALOGIC REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* SEES FY REVENUE $93.0 MILLION TO $98.0 MILLION
* Q3 2022 REVENUE OF $41.7 MILLION VERSUS $20 MILLION
* QTRLY NET LOSS WAS $0.18 PER SHARE
* Q3 EARNINGS PER SHARE VIEW $-0.20, REVENUE VIEW $20.1
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3XhKKG
Further company coverage: SLGC.O
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders